Table 2 Characteristics of CR-KP and CS-KP isolates
CR-KP | CS-KP | |
|---|---|---|
Number of different patients | 28 | 14 |
Period of isolation | Oct 2010- Dec 2012 | Dec 2010- May 2012 |
Betalactamase production | CTX-M-15 and OXA-48 | CTX-M-15 |
PFGE profile and subtypes | PFGE-1 | PFGE-1 and 6 subtypes |
MLST | 101 | 101 |
Antimicrobial susceptibility | ||
Antimicrobial | MIC range (mg/L) | MIC range (mg/L) |
Gentamycin | >8 | >8 |
Amikacin | <8 | <8 |
Cotrimoxazole | >4 | >4 |
Ciprofloxacin | >2 | >2 |
Imipenem | 2 / >32 | <2 |
Meropenem | 4 / >32 | <2 |
Ertapenem | 8 / >32 | <8 |